Streetbeat News

Earnings

ROP

Roper Technologies (NASDAQ:ROP) reported Q2 2024 adjusted EPS of $4.48, beating the estimate of $4.46. However, sales of $1.720 billion missed the $1.732 billion estimate. Sales increased by 12.34% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:56 am

THC

Tenet Healthcare has significantly raised its 2024 financial outlook, forecasting adjusted EPS of $10.41-$11.12, up from prior guidance of $8.37-$9.41 and consensus of $8.98. Revenue projections have also increased to $20.6B-$21B, compared to prior guidance of $20B-$20.4B and consensus of $20.493B. The outlook reflects the sale of several hospitals in South Carolina and California.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:55 am

WNC

Wabash National (NYSE:WNC) reported Q2 2024 adjusted EPS of $0.64, beating the estimate of $0.56, but sales of $550.610M missed the $594.740M estimate. EPS decreased by 58.44% YoY, and sales decreased by 19.81% YoY.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:54 am

EVR

Evercore (NYSE:EVR) reported Q2 2024 adjusted EPS of $1.81, beating the estimate of $1.63. Sales were $695.270M, surpassing the $611.910M estimate and showing a 37.64% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:53 am

LII

Lennox International Inc. (LII) has raised its FY24 EPS guidance from $19.00 - $20.00 to $19.50 - $20.25, compared to the $20.09 estimate.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:50 am

TNL

Travel + Leisure has updated its 2024 adjusted EBITDA forecast to $915M-$935M, up from the previous outlook of $910M-$930M. The company also expects Q3 adjusted EBITDA to be $235M-$245M.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:50 am

PFE

Pfizer has announced positive topline results from a Phase 3 study of its hemophilia A gene therapy candidate, Giroctocogene Fitelparvovec. The study met its primary and key secondary objectives, demonstrating superiority compared to prophylaxis.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:49 am

AJX

Great Ajax (NYSE:AJX) reported Q2 2024 adjusted EPS of $(0.24), missing the $(0.15) estimate by 60%. Sales were $(8.958M), missing the $4.983M estimate by 279.77% and down 271.09% from last year's $(2.414M).

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:48 am

LII

Lennox International (NYSE:LII) reported Q2 earnings of $6.83 per share, beating the analyst estimate of $6.57. However, sales of $1.45 billion missed the $1.48 billion estimate. Earnings increased by 11.06% year-over-year, while sales grew by 2.83%.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:48 am

THC

Tenet Healthcare reported Q2 2024 adjusted EPS of $2.31, beating the estimate of $1.90. Sales were $5.103 billion, surpassing the expected $5.003 billion.

Portfolio Pulse from Benzinga Newsdesk

July 24, 2024 | 10:46 am